DrugPatentWatch Database Preview
CLINICAL TRIALS PROFILE FOR INSULIN ASPART RECOMBINANT
Clinical Trials for Insulin Aspart Recombinant
| Trial ID | Title | Status | Sponsor | Phase | Summary |
|---|---|---|---|---|---|
| NCT00046150 | 12 Week,Comparing Safety of HMR1964 & Insulin Aspart Used in Continuous Subcutaneous Infusion in Type 1 Diabetes. | Completed | Sanofi | Phase 3 | The purpose of this study is to compare the safety of HMR 1964 and insulin aspart when used in external pumps with respect to catheter occlusions, GHb assessment, insulin doses, blood glucose parameters, hypoglycemic episodes, unexplained hyperglycemia, adverse events, laboratory data, and vital signs. |
| NCT00065130 | Safety and Efficacy of Insulin Aspart vs. Regular Human Insulin in Gestational Diabetes | Completed | Novo Nordisk A/S | Phase 3 | This trial is conducted in the United States of America (USA). The purpose of this study is to test whether NovoLog (insulin aspart) is a safe and at least as effective alternative to regular human insulin for the control of blood glucose after meals in women who develop diabetes during pregnancy. |
| NCT00071448 | Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population | Completed | Novo Nordisk A/S | Phase 3 | This trial is conducted in the United States of America (USA). The aim of this trial is to to determine whether insulin aspart can be used effectively and safely in paediatric patients. |
| Trial ID | Title | Status | Sponsor | Phase | Summary |
Clinical Trial Conditions for Insulin Aspart Recombinant
Clinical Trial Locations for Insulin Aspart Recombinant
Trials by Country
Clinical Trial Progress for Insulin Aspart Recombinant
Clinical Trial Phase
Clinical Trial Status
Clinical Trial Sponsors for Insulin Aspart Recombinant
Sponsor Name
